The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia

Archives of General Psychiatry

Volumn 69, Issue 3, 2012, Pages 265-273

  Kopelowicz, Alex ^a   Zarate, Roberto ^a   Wallace, Charles J ^a   Liberman, Robert Paul ^a   Lopez, Steven R ^b   Mintz, Jim ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; DISEASE EXACERBATION; FAMILY THERAPY; FEMALE; HISPANIC; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; FAMILY THERAPY; FEMALE; HOSPITALIZATION; HUMANS; LOS ANGELES; MALE; MEDICATION ADHERENCE; MEXICAN AMERICANS; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; SCHIZOPHRENIA;

EID: 84857944959     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.135     Document Type: Article

References (45)

1. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892-909. (Pubitemid 35231730)
2. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161(4):692-699. (Pubitemid 38445514)
3. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry. 2006;67(3):453-460.
4. Woodward AM, Dwinell AD, Arons BS. Barriers to mental health care for Hispanic Americans: a literature review and discussion. J Ment Health Adm. 1992; 19(3):224-236.
5. Alegría M, Canino G, Ríos R, Vera M, Calderón J, Rusch D, Ortega AN. Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatr Serv. 2002;53(12):1547-1555. (Pubitemid 35404030)
6. Hosch HM, Barrientos GA, Fierro C, Ramírez JI, Pelaez MP, Cedillos AM, Meyer LD, Perez Y. Predicting adherence to medications by Hispanics with schizophrenia. Hisp J Behav Sci. 1995;17:320-333.
7. US Department of Health and Human Services. Mental Health: Culture, Race, and Ethnicity-A Supplement to Mental Health: A Report of the Surgeon General. Rockville, MD: US Public Health Service; 2001.
8. US Census Bureau. Statistical Abstract of the United States: 2009. 128th ed. Washington, DC; 2008. http://www.census.gov/compendia/statab/. Accessed August 31, 2011.
9. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23(4):637-651. (Pubitemid 27485972)
10. Sellwood W, Tarrier N, Quinn J, Barrowclough C. The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion. Psychol Med. 2003;33(1):91-96. (Pubitemid 36113404)
11. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;51(2):216-222. (Pubitemid 30082525)
12. Lanouette NM, Folsom DP, Sciolla A, Jeste DV. Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review. Psychol Serv. 2009;60(2):157-174.
13. Frauenglass S, Routh DK, Pantin HM, Mason CA. Family support decreases influence of deviant peers on Hispanic adolescents' substance use. J Clin Child Psychol. 1997;26(1):15-23.
14. Kopelowicz A, Zarate R, Gonzalez Smith V, Mintz J, Liberman RP. Disease management in Latinos with schizophrenia: a family-assisted, skills training approach. Schizophr Bull. 2003;29(2):211-227. (Pubitemid 37187686)
15. Falloon IRH, Liberman RP, Lillie FJ, Vaughn CE. Family therapy of schizophrenics with high risk of relapse. Fam Process. 1981;20(2):211-221.
16. McFarlane WR. Multifamily Groups in the Treatment of Severe Psychiatric Disorders. New York, NY: Guilford Press; 2002.
17. McFarlane WR, Lukens E, Link B, Bushay R, Deakins SA, Newmark M, Dunne EJ, Horen B, Toran J. Multiple-family group and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry. 1995;52(8):679-687.
18. McFarlane WR, Dushay RA, Stastny P, Deakins SM, Link B. A comparison of two levels of family-aided assertive community treatment. Psychiatr Serv. 1996; 47(7):744-750. (Pubitemid 26242035)
19. Dyck DG, Short RA, Hendryx MS, Norell D, Myers M, Patterson T, McDonell MG, Voss WD, McFarlane WR. Management of negative symptoms among patients with schizophrenia attending multiple-family groups. Psychiatr Serv. 2000; 51(4):513-519. (Pubitemid 30212095)
20. McFarlane WR, Dushay RA, Deakins SM, Stastny P, Lukens EP, Toran J, Link B. Employment outcomes in family-aided assertive community treatment. Am J Orthopsychiatry. 2000;70(2):203-214. (Pubitemid 30262904)
21. Hazel NA, McDonell MG, Short RA, Berry CM, Voss WD, Rodgers ML, Dyck DG. Impact of multiple-family groups for outpatients with schizophrenia on caregivers' distress and resources. Psychiatr Serv. 2004;55(1):35-41. (Pubitemid 38045013)
22. Lopez SR, Kopelowicz A, Cañive J. Strategies in developing culturally congruent family interventions for schizophrenia: the case of Hispanics. In: Lefley HP, Johnson DL, eds. Family Interventions in Mental Illness: International Perspectives. Westport, CT: Praeger; 2002:61-92.
23. Lakes K, Lopez SR, Garro L. Cultural competence and psychotherapy: applying anthropologically informed conceptions of culture. Psychother. 2006;43:380-396.
24. Ajzen I. The Theory of Planned Behavior. Organ Behav Hum Decis Process. 1991; 50:179-211.
25. Armitage CJ, Conner M. Efficacy of the Theory of Planned Behaviour: a metaanalytic review. Br J Soc Psychol. 2001;40(pt 4):471-499. (Pubitemid 33597358)
26. Anderson C, Hogarty G, Reiss D. Schizophrenia and the Family. New York, NY: Guilford Press; 1986.
27. D'Zurilla TJ, Goldfried MR. Problem solving and behavior modification. J Abnorm Psychol. 1971;78(1):107-126.
28. Kopelowicz A, Wallace CJ, Liberman RP, Aguirre F, Zarate R, Mintz J. The use of the Theory of Planned Behavior to predict medication adherence in schizophrenia. Clin Schiz & Rel Psychoses. 2007;1(2):227-242.
29. Jenkins JH. Subjective experience of persistent schizophrenia and depression among US Latinos and Euro-Americans. Br J Psychiatry. 1997;171:20-25.
30. Sabogal F, Marin G, Otero-Sabogal R, Marin BV, Perez-Stable EJ. Hispanic familism and acculturation: what changes and what doesn't? Hisp J Behav Sci. 1987;9(4):397-412.
31. Guarnaccia PJ, Parra P. Ethnicity, social status, and families' experiences of caring for a mentally ill family member. Community Ment Health J. 1996;32(3): 243-260. (Pubitemid 26185284)
32. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P). Washington, DC: American Psychiatric Press; 1996.
33. Weiden PJ, Mott T, Curcio N. Recognition and management of neuroleptic non-compliance. In: Shriqui C, Nasrallah H, eds. Contemporary Issues in the Treatment of Schizophrenia. New York, NY: Raven Press; 1995:463-485.
34. Lukoff D, Nuechterlein KH, Ventura J. Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophr Bull. 1986;12(3):594-602.
35. Ventura J, Green MF, Shaner A, Liberman RP. Training and quality assurance on the BPRS: "the drift busters." Int J Methods Psychiatr Res. 1993;3:221-224.
36. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7(1):83-104.
37. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182.
38. Sobel ME. Asymptotic intervals for indirect effects in structural equations models. In: Leinhart S, ed. Sociological Methodology 1982. San Francisco, CA: Jossey-Bass; 1982:290-312.
39. Fairchild AJ, Mackinnon DP, Taborga MP, Taylor AB. R2 effect-size measures for mediation analysis. Behav Res Methods. 2009;41(2):486-498.
40. Masanet MJ, Montero I, Lacruz M, Bellver F, Hernandez I. Long-term outcome of family therapy in schizophrenia. Clin Schiz & Rel Psych. 2007;1:168-174.
41. Vargas Bustamante A, Fang H, Rizzo JA, Ortega AN. Understanding observed and unobserved health care access and utilization disparities among US Latino adults. Med Care Res Rev. 2009;66(5):561-577.
42. Barrio C, Yamada AM, Hough RL, Hawthorne W, Garcia P, Jeste DV. Ethnic disparities in use of public mental health case management services among patients with schizophrenia. Psychiatr Serv. 2003;54(9):1264-1270. (Pubitemid 37055989)
43. Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA. 2003;290(1):57-65. (Pubitemid 37432866)
44. Miranda J, Schoenbaum M, Sherbourne C, Duan N, Wells K. Effects of primary care depression treatment on minority patients' clinical status and employment. Arch Gen Psychiatry. 2004;61(8):827-834. (Pubitemid 39031122)
45. Telles C, Karno M, Mintz J, Paz G, Arias M, Tucker D, Lopez S. Immigrant families coping with schizophrenia: behavioral family intervention v. case management with a low-income Spanish-speaking population. Br J Psychiatry. 1995; 167(4):473-479. (Pubitemid 26194148)